Teresa R Franklin1, Kanchana Jagannathan2, Nathan Hager2, Zhuo Fang3, Sihua Xu4, Joyce Wong2, Anna Rose Childress2, John A Detre5, Hengyi Rao3, Reagan Wetherill2. 1. Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, 19104, USA. Electronic address: teresafr@pennmedicine.upenn.edu. 2. Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, 19104, USA. 3. Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Neurology, University of Pennsylvania, Philadelphia, PA, 19104, USA; Laboratory of Applied Brain and Cognitive Sciences, Shanghai International Studies University, Shanghai, China. 4. Department of Neurology, University of Pennsylvania, Philadelphia, PA, 19104, USA; Laboratory of Applied Brain and Cognitive Sciences, Shanghai International Studies University, Shanghai, China. 5. Department of Neurology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Abstract
INTRODUCTION: Research indicates that overnight nicotine abstinence disrupts neural activity in the mesocorticolimbic reward network; however, less is known about the time course of abstinence-induced brain changes. To examine the potential neural effects of early abstinence, we used arterial spin labeling perfusion fMRI, to measure regional cerebral blood flow (rCBF) changes in the resting brain induced by 4h of nicotine abstinence. METHODS: In a repeated measures design, 5min of resting perfusion fMRI data were acquired in awake nicotine-dependent individuals (eyes open) during 'smoking as usual' (SMK) and following 4h of monitored nicotine abstinence (ABS) conditions (N=20). Conditions were compared using a paired t test in SPM8. Craving was assessed prior to each condition. RESULTS: Compared to SMK, ABS significantly increased craving and reduced rCBF in select regions, including the hippocampus and ventral striatum (cluster corr, α=0.01, 943 contiguous voxels). The magnitude of the abstinence-induced change in rCBF correlated with the magnitude of the change in craving across conditions in select regions, including the medial and lateral orbitofrontal cortices and the anterior ventral insula (r values ranging from 0.59-0.74). CONCLUSIONS: Results show that as few as 4h of abstinence can reduce resting rCBF in multiple nodes of the brain's mesocorticolimbic network, disrupting neural processing. Identifying early withdrawal treatment targets has far-reaching implications, which include thwarting relapse proclivities. Results parallel those of the extant human literature and are in agreement with an extensive preclinical literature showing compromised mesolimbic dopaminergic function and impairments in reward function during nicotine withdrawal.
INTRODUCTION: Research indicates that overnight nicotine abstinence disrupts neural activity in the mesocorticolimbic reward network; however, less is known about the time course of abstinence-induced brain changes. To examine the potential neural effects of early abstinence, we used arterial spin labeling perfusion fMRI, to measure regional cerebral blood flow (rCBF) changes in the resting brain induced by 4h of nicotine abstinence. METHODS: In a repeated measures design, 5min of resting perfusion fMRI data were acquired in awake nicotine-dependent individuals (eyes open) during 'smoking as usual' (SMK) and following 4h of monitored nicotine abstinence (ABS) conditions (N=20). Conditions were compared using a paired t test in SPM8. Craving was assessed prior to each condition. RESULTS: Compared to SMK, ABS significantly increased craving and reduced rCBF in select regions, including the hippocampus and ventral striatum (cluster corr, α=0.01, 943 contiguous voxels). The magnitude of the abstinence-induced change in rCBF correlated with the magnitude of the change in craving across conditions in select regions, including the medial and lateral orbitofrontal cortices and the anterior ventral insula (r values ranging from 0.59-0.74). CONCLUSIONS: Results show that as few as 4h of abstinence can reduce resting rCBF in multiple nodes of the brain's mesocorticolimbic network, disrupting neural processing. Identifying early withdrawal treatment targets has far-reaching implications, which include thwarting relapse proclivities. Results parallel those of the extant human literature and are in agreement with an extensive preclinical literature showing compromised mesolimbic dopaminergic function and impairments in reward function during nicotine withdrawal.
Authors: Jon-Kar Zubieta; Mary M Heitzeg; Yanjun Xu; Robert A Koeppe; Lisong Ni; Sally Guthrie; Edward F Domino Journal: Am J Psychiatry Date: 2005-03 Impact factor: 18.112
Authors: Eric D Claus; Sara K Blaine; Francesca M Filbey; Andrew R Mayer; Kent E Hutchison Journal: Neuropsychopharmacology Date: 2013-05-24 Impact factor: 7.853
Authors: Bernard Le Foll; Mihail Guranda; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Victoria C Wing; Laurie Zawertailo; Usoa Busto; Peter Selby; Arthur L Brody; Tony P George; Isabelle Boileau Journal: Neuropsychopharmacology Date: 2013-08-19 Impact factor: 7.853
Authors: Amy C Janes; Robert S Ross; Stacey Farmer; Blaise B Frederick; Lisa D Nickerson; Scott E Lukas; Chantal E Stern Journal: Addict Biol Date: 2013-11-22 Impact factor: 4.280
Authors: Bader Chaarani; Philip A Spechler; Alexandra Ivanciu; Mitchell Snowe; Joshua P Nickerson; Stephen T Higgins; Hugh Garavan Journal: Nicotine Tob Res Date: 2019-05-21 Impact factor: 4.244
Authors: Edith V Sullivan; Qingyu Zhao; Kilian M Pohl; Natalie M Zahr; Adolf Pfefferbaum Journal: J Psychiatr Res Date: 2021-02-02 Impact factor: 4.791